T-cell epitope determination

Current Opinion in Immunology

Volumn 8, Issue 1, 1996, Pages 68-74

  Walden, Peter ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE;

ALLELE; AMINO ACID SEQUENCE; ANTIGEN PRESENTATION; ANTIGEN RECOGNITION; CELL; CRYSTAL STRUCTURE; EPITOPE MAPPING; IMMUNITY; MAJOR HISTOCOMPATIBILITY COMPLEX; REVIEW; T LYMPHOCYTE;

EID: 0029966728     PISSN: 09527915     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0952-7915(96)80107-5     Document Type: Article

References (60)

1. Barber LD, Parham P: Peptide binding to major histocompatibility complex molecules. Annu Rev Cell Biol 1993, 9:163-206.
2. Niedermann G, Butz S, Ihlenfeldt HG, Grimm R, Lucchiari M, Hoschützky H, Jung G, Maier B, Eichmann K: Cantributlon of proteasome-mediated proteolysis to the hierarchy of epitopes presented by major histocompatibility complex class I molecules. Immunity 1995, 2:289-299.
3. Momberg F, Roelse J, Hämmerling GJ, Neefjes JJ: Peptide size selection by the major histocompatibility complex-encoded. peptide transporter. J Exp Med 1994, 179:1613-1623.
4. Schumacher TNM, Kantesaria DV, Heemels MT, Ashton-Rickardt PG, Shepherd JC, Fruh K, Peterson PA, Tonegawa S, Ploegh HL: Peptide length and sequence specificity of the mouse TAP1/TAP2 translocator. J Exp Med 1994, 179:533-540.
5. Uebel S, Meyer TH, Kraas W, Kienle S, Jung G, Wiesmüller KH, Tampé R: Requirements for peptide binding to the human transporter associated with antigen processing revealed by peptide scans and complex peptide libraries. J Biol Chem 1995, 270:18512-18516.
6. Schirmbeck R, Reimann J: Peptide transporter-independent, stress protein-mediated endosomal processing of endogenous protein antigens for major histocompatibility complex class I presentation. Eur J Immunol 1994, 24:1478-1486.
7. Germain RN, Margulies DH: The biochemistry and cell biology of antigen processing and presentation. Annu Rev Immunol 1993, 11:403-450.
8. Madden DR: The three-dimensional structure of peptide-MHC complexes. Annu Rev Immunol 1995, 13:587-622.
9. Hunt DF, Henderson RA, Shabanowitz J, Sakaguchi K, Michel H, Selilir N, Cox A, Appella E, Engelhard VH: Characterization of peptides bound to the class II molecules HLA-A2.1 by mass spectometry. Science 1992, 255:1261-1263.
10. Rammensee H-G, Friede T, Stevanovic S: MHC ligands and peptide motifs: first listing. Immunogenetics 1995, 41:178-228. This is a comprehensive list of MHC allele-specific peptide sequence motifs and T-cell epitopes that conform to these motifs.
11. Ruppert J, Grey HM, Sette A, Kubo RT, Sidney J, Celis E: Prominent role of secondary anchor residues in peptides binding to A2.1 molecules. Cell 1993, 74:929-937.
12. Sinigaglia F, Hammer J: Motifs and supermotifs for MHC class II binding peptides. J Exp Med 1995, 181:449-451.
13. Hammer J, Valsasnini P, Tolba K, Bolin D, Higelin J, Takacs B, Sinigaglia F: Promiscuous and allele-specific anchors in HLA-DR-binding peptides. Cell 1993, 74:197-203.
14. Sidney J, Delguercio MF, Southwood S, Engelhard VH, Appella E, Rammensee H-G, Falk K, Rötzschke O, Takaguchi M, Kubo RT et al.: Several HLA alleles share overlapping peptide specificities. J Immunol 1995, 154:247-259.
15. Delguercia MF, Sidney J, Hermanson G, Perez C, Grey HM, Kubo RT, Sette A: Binding of a peptide antigen to multiple HLA alleles allows definition of an A2-like supermotif. J Immunol 1995, 154:685-693.
16. Barber LD, Gillece-Castro B, Percival L, Li X, Clayberger C, Parhan P: Overlap in the repertoires of peptides bound in vivo by a group of related class I HLA-B allotypes. Curr Biol 1995, 5:179-190.
17. •] report the identification of the long sought male-specific cytotoxic T-cell antigen H-Y.
18. Bartholomew JS, Stacey SN, Coles B, Burt DJ, Arrand JR, Stern PL: Identification of a naturally processed HLA A0201-restricted viral peptide from cells expressing human papillomavirus type 16 E6 oncoprotein. Eur J Immunol 1994, 24:3175-3179.
19. Man S, Newberg MH, Crotzer VL, Lyckey CJ, Williams NS, Chen Y, Huczko EL, Ridge JP, Engelhard VH: Definition of a human T cell epitope from influenza A non-structural protein 1 using HLA-A2.1 transgenic mice. Int Immunol 1995, 7:597-605.
20. Kawakami Y, Eliyahu S, Jennings C, Sakaguchi K, Kang XQ, Southwood S, Robbins PF, Sette A, Appella E, Rosenberg SA: Recognition of multiple epitopes in the human melanoma antigen Gp 100 by tumor-infiltrating T lymphocytes associated with in vivo tumor regression. J Immunol 1995, 154:3961-3968.
21. Ressing ME, Sette A, Brandt RMP, Ruppert J, Wentworth PA, Harman M, Oseroff C, Grey HM, Melief CJM, Kast WM: Human CTL epitopes encoded by human papillomavirus type 16 E6 and E7 indentified through in vitro and in vivo immunogenicity studies of HLA-A*0201-binding peptides. J Immunol 1995, 154:5934-5943.
22. Hill A, Worth A, Elliott T, Rowlandjones S, Brooks J, Rickinson A, McMichael A: Characterization of two Epstein-Barr-virus epitopes restricted by HLA-B7. Eur J Immunol 1995, 25:18-24.
23. ••].
24. b major histocompatibility complex class I molecules and presented to cytotoxic T lymphocytes. J Virol 1995, 69:2297-2305.
25. ••].
26. Coulie PG, Lehmann F, Lethe B, Herman J, Lurquin C, Andrawiss M, Boon T: A mutated intron sequence codes for an antigenic peptide recognized by cytolytic T lymphocytes on a human melanoma. Proc Natl Acad Sci USA 1995, 92:7976-7980.
27. Oftung F, Geluk A, Lundin KEA, Meloen RH, Thole JER, Mustafa A, Ottenhoff THM: Mapping of multuple HLA class II-restricted T-cell epitopes of the mycobacterial 70-kilodalton heat shock protein. Infect Immun 1994, 62:5411-5418.
28. Celis E, Fikes J, Wentworth P, Sidney J, Southwood S, Maewal A, Delguercio MF, Sette A, Livingston B: Identification of potential CTL epitopes of tumor-associated antigen MAGE-1 for five common HLA-A alleles. Mol Immunol 1994, 31:1423-1430.
29. Sadovnikova E, Zhu X, Collins SM, Zhou J, Vousden K, Crawford L, Beverly P, Stauss HJ: Limitations of predictive motifs revealed by cytotoxic T lymphocyte epitope mapping of the human papilloma virus E7 protein. Int immunol 1994, 6:289-296.
30. Mandelboim O, Berke G, Fridkin M, Feldman M, Eisenstein M, Eisenbach L: CTL induction by tumour-associated antigen octapeptide derived from a murine lung carcinoma. Nature 1994, 369:67-71.
31. Gavin MA, Gilbert MJ, Riddell SR, Greenberg RD, Bevan MJ: Alkali hydrolysis of recombinant protein allows for the rapid identification of class I MHC-restricted CTL epitopes. J Immunol 1993, 151:3971-3980.
32. Falk K, Rötzschke O, Stevanovic S, Gnau V, Sparbier K, Jung G, Rammensee HG, Walden P: Analysis of a naturally occuring HLA class I-restricted viral epitope. Immunology 1994, 82:337-342.
33. Rötzschke O, Falk K, Stevanovic S, Jung G, Walden P, Rammensee HG: Exact prediction of a natural T cell epitope. Eur J Immunol 1991, 21:2891-2894.
34. + cytotoxic T lymphocytes in association with a class I MHC protein. Cell 1992, 69:989-998.
35. •].
36. ••].
37. ••].
38. + T-celI clone. Proc Natl Acad Sci USA 1993, 90:11272-11276.
39. Walden P, Wiesmüller KH, Jung G: Elucidation of T cell epitopes: a synthetic approach with random peptide libraries. Biochem Soc Trans 1995, 23:678-681.
40. Dooley CT, Houghten RA: The use of positional scanning synthetic peptide combinatorial libraries for the rapid determination of opoid receptor ligands. Life Sci 1992, 52:1509-1517.
41. Chen WS, Khilko S, Fecondo J, Margulies DH, McCluskey J: Determinant selection of major histocompatibillty complex class I-restricted antigenic peptides is explained by class I-peptide affinity and is strongly influenced by nondominant anchor residues. J Exp Med 1994, 180:1471-1483.
42. Sette A, Vitiello A, Retherman B, Fowler P, Nayersina R, Kast WM, Melief CJM, Oseroff C, Yuan L, Ruppert J et al.: The relationship between class I binding affinity and immunogenicity of potential cytotoxic T cell epitopes. J Immunol 1994, 153:5586-5592.
43. Parker KC, Shields M, Dibrino M, Coligan JE: Peptide binding to MHC class I molecules - implications for antigenic peptide prediction. Immunol Res 1995, 14:34-57.
44. Hammer J, Bono E, Gallazzi F, Belunis C, Nagy ZA, Sinigaglia F: Precise prediction of major histocompatibility complex class II peptide interaction based on peptide side chain scanning. J Exp Med 1994, 180:2353-2358.
45. •].
46. b. J Biol Chem 1995, 270:24130-24134.
47. b. Science 1992, 257:919-927.
48. Damaro J, Houbiers JGA, Drijfhout JW, Brandt RMP, Schipper R, Bavinck JNB, Melief CJM, Kast MW: A computer program for prediction of possible cytotoxic T-lymphocyte epitopes based on HLA class I peptide-binding motifs. Human Immunol 1995, 43:13-18.
49. Meister GE, Roberts CGP, Berzofsky JA, Degroot AS: Two novel T cell epitope prediction algorithms based on MHC-binding motifs. Vaccine 1995, 13:581-591.
50. Thorpe CJ, Travers PJ: Prediction of an HLA-B44 binding motif by alignment of known epitopes and molecular modeling of the antigen binding cleft. Immunogentics 1994, 40:303-305.
51. Parker KC, Bednarek MA, Coligan JE: Scheme for ranking potential HLA-A2 binding peptides based on independent binding of individual peptide side-chains. J Immunol 1994, 152:163-175.
52. d binding peptides and induction of peptide specific CTL J Immun Methods 1994, 176:245-253.
53. Gavin MA, Dere B, Grandea AG III, Hogquist KA, Bevan MJ: Major histocompatibility complex class I allele-specific peptide libraries: identification of peptides that mimic an H-Y T cell epitope. Eur J Immunol 1994, 24:2124-2133.
54. Cole GA, Hogg TL, Woodland DL: The MHC class I-restricted T cell response to Sendai virus infection In C57BL/6 mice: a single immunodominant epitope elicits and extremely diverse repertoire of T cells. Int Immunol 1994, 6:1767-1775.
55. Feiertag S, Gnau V, Udaka K, Walden P, Jung G, Wiesmüller KH: Coupling methods for X-positions in octapeptide mixtures applied in competition experiments with killer cells. In Innovations and Perspectives in Solid Phase Synthesis. Edited by Epton R. Birmingham, England: Mayflower Worldwide Ltd; 1994:501-504.
56. Schoel B, Zugel U, Ruppert T, Kaufmann SHE: Elongated peptides, not the predicted nonapeptide stimulate a major histocompatibility complex class I-restricted cytotoxic T lymphocyte clone with specificity for a bacterial heat shock protein. Eur J Immunol 1994, 24: 3161-3169.
57. •].
58. Borges E, Wiesmüller KH, Jung G, Walden P: Efficacy of synthetic vaccines in the Induction of cytotoxic T lymphocytes. J Immunol Meth 1994, 173:253-263.
59. d. Eur J Biochem 1996, in press.
60. Gundlach BR, Wiesmüller KH, Junt T, Kienle S, Jung G, Walden P: Determination of T cell epitopes with random peptide libraries. J Immunol Methods 1996, in press.